Doctor consultations
Initial visits, follow-ups, and repeat testing when clinically appropriate. Build continuity around real services, not a requirement to buy a product.
Value: ongoing access to carePlatform
White-label telehealth that starts with bloodwork, connects members with licensed doctor consultations, and supports eligible 503A pharmacy pathways and optional supplements. Add your own qualified coaching around the member experience; clinicians retain control of care.
$0 to start$0 until you're liveno cardcancel anytime
WellStaq is a white-label telehealth platform that lets platform connect bloodwork, licensed doctor consultations, eligible 503A pharmacy services, and optional supplements under their own brand. Independent clinicians control care; compounded drugs are not FDA-approved.
THE BLOODWORK-FIRST BUSINESS MODEL
A one-time product ends at checkout. A lab-led experience gives members a starting point, access to a doctor, and relevant ways to keep going—all through your white-label telehealth brand.
THE STARTING POINT
Invite members to start with a blood panel, with clinician ordering where required. Results appear in their branded member experience, with access limited to authorized users.
THE CLINICAL CHECKPOINT
A licensed doctor reviews the results alongside health history, symptoms, and goals in a consultation. The clinician—not a sales funnel—determines what care is appropriate.
From there: relevant options, not automatic upsells.
HOW THE BUSINESS GROWS
Earn from products and nonclinical services your business actually provides. Clinical and pharmacy services have separate charges and arrangements; brand ownership does not entitle you to medical fees or prescription commissions. Revenue depends on demand, costs, member choice, and lawful agreements—not every member needs every service.
White-label experience, transparent care. Your brand leads the experience; the treating provider and dispensing pharmacy must remain clearly identified. WellStaq and your brand are not the compounder or the prescriber.
503A is a compounding framework, not FDA approval. Compounded drugs are not FDA-approved; FDA does not review their safety, effectiveness, or quality before marketing. A valid prescription alone does not establish that every product can legally be compounded. Availability depends on the patient, clinician, pharmacy, state, and applicable requirements. No prescription, refill, or outcome is guaranteed.
Data informs care—not a marketing list. Health information must be used only for permitted purposes with required privacy authorizations and safeguards. Coaching is not diagnosis or treatment; supplements are not represented as treating disease. Clinical fees, pharmacy charges, and any management agreements need state-specific legal review, including fee-splitting and referral restrictions.
503A availability is conditional. Compounded drugs are not FDA-approved. Coaching is supplied by your own qualified team, not included clinical staff. Lab, clinical, pharmacy, and product charges are separate from platform access.
Build your bloodwork-first brand$997/mo $297/mo for the first 100 Early Adopters. Lifetime price lock. Save $700/month.
A recognizable model. Your own brand.
Think Function Health-style lab memberships and Hims-style access to care, brought together under your own brand. Start with bloodwork, connect members with a licensed doctor, then support appropriate next steps. These are business-model references, not affiliations; services and results differ.
Familiar access to care, with transparent clinical roles.
Launch in weeks, for a flat fee — no raise required.
Connectivity to national lab networks for current-state biomarker panels.
Panels pass through at wholesale; you set retail and keep the margin on labs.
Results land in the branded patient app as part of a unified health record.
Genetic pathway reports produced through CLIA-certified labs.
Reports map variants to pathways as an educational roadmap, not a diagnosis or prescription.
The report is presented under your brand inside the patient app.
Phone and video consults with the independent, board-certified network licensed in all 50 states.
Consultations are real clinical services, not automatic brand-owner margin. Clinical fees and any management arrangements must follow applicable state and federal rules.
Access to health information must be limited to authorized purposes and users, with required agreements, safeguards, and privacy authorizations.
A prescribing capability owned entirely by the independent, board-certified network; you never prescribe.
Licensed pharmacies may dispense eligible compounded medications pursuant to a valid patient-specific prescription, when all applicable requirements are met. Availability varies; no product or prescription is guaranteed.
Compounded drugs are not FDA-approved; FDA does not review their safety, effectiveness, or quality before marketing. White-label branding must not hide the treating provider or dispensing pharmacy.
A supplement line presented entirely under your name.
Products arrive at wholesale; you set retail and keep the margin on supplements.
Members choose whether to purchase or reorder. Product claims must be supported; supplements are not positioned as disease treatments or automatic responses to lab results.
Labs, genetic reports, telehealth, refills, and supplements in one app under your brand.
Blood and genetic data sit together in a longitudinal patient view.
You manage the experience while the independent network manages clinical care.
You're really choosing between sending patients to someone else's brand, building it all yourself, or owning the model on Wellstaq.
How the economics work
Standard $997/mo. First 100 Early Adopters: $297/mo with a lifetime price lock. Save $700/month — $8,400 every year on platform access. Lead with bloodwork, connect members with licensed telehealth and eligible 503A pharmacy services, and offer optional supplements, your own qualified coaching, and memberships. WellStaq takes 0% of your sales. Lab, clinical, pharmacy, product, and operating costs are separate; clinical fees and any management arrangements must follow applicable rules. No prescription commissions or earnings are promised.
The independent, board-certified provider network, licensed in all 50 states, owns all clinical and prescribing decisions. Brand ownership does not authorize clinical practice; health information access must be restricted by role and lawful purpose.
Standard platform access is $997/mo. The first 100 Early Adopters get $297/mo for the life of their account, saving $700/month and $8,400/year. Lab, clinical, pharmacy, product, and optional add-on charges are separate. WellStaq takes 0% of your sales. Clinical fees and pharmacy charges follow separate lawful billing arrangements; any management fees require state-specific review. WellStaq does not promise prescription commissions.
Save $700/month — $8,400/year. The first 100 Early Adopters to sign up get $297/mo locked in for life, instead of standard $997/mo. Join the free waitlist for your invitation when enrollment opens.
$0 to start$0 until you're liveno cardcancel anytime
WellStaq provides white-label telehealth technology and brand infrastructure, not medical care. Independent licensed providers make clinical and prescribing decisions. Eligible 503A pharmacy services require a valid patient-specific prescription and compliance with applicable requirements; availability varies. Compounded drugs are not FDA-approved. Provider and pharmacy identities remain disclosed. Health data is used only for permitted purposes with required safeguards and authorizations. Billing, marketing, privacy, and management arrangements need state-specific legal review. No health or earnings outcome is guaranteed.